Drug-Drug Interactions between COVID-19 and Tuberculosis Medications: A Comprehensive Review of CYP450 and Transporter-Mediated EffectsReview Published on 2024-08-062024-09-05 Journal: Pharmaceuticals [Category] update2024, [키워드] Anti-tuberculosis COVID-19 Drug-drug interactions enzyme transporter [DOI] 10.3390/ph17081035 PMC 바로가기 [Article Type] Review
Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19Health Archive Original Research Published on 2024-03-262024-09-05 Journal: Transplant International [Category] update2024, [키워드] drug monitoring Drug-drug interactions Nirmatrelvir/ritonavir pharmacokinetic modelling tacrolimus [DOI] 10.3389/ti.2024.12360 PMC 바로가기 [Article Type] Health Archive Original Research
Utility of sustainable ratio derivative spectrophotometry for the concurrent assay of synergistic repurposed drugs for COVID-19 infections; Insilico pharmacokinetics proofResearch Published on 2024-03-072024-09-05 Journal: BMC Chemistry [Category] update2024, [키워드] COVID-19 Drug-drug interactions fluvoxamine green Insilico Ivermectin Repurposed Spectrophotometry synchronous [DOI] 10.1186/s13065-024-01147-w PMC 바로가기 [Article Type] Research
Drug-Drug Interactions Between COVID-19 Treatments and Psychotropic Medications: An Updated StudyPsychiatry Published on 2023-12-132024-09-05 Journal: Cureus [Category] update2024, [키워드] antidepressants Antipsychotics benzodiazepines COVID 19 Drug-drug interactions medication therapy management Mood stabilizers Psychotropic [DOI] 10.7759/cureus.50469 PMC 바로가기 [Article Type] Psychiatry
Pharmacokinetics under the COVID-19 stormarticle Published on 2023-01-012024-09-02 Journal: British Journal of Clinical Pharmacology [Category] 대상포진, [키워드] ADME COVID-19 cytokine Drug-drug interactions PBPK PKPD [DOI] 10.1111/bcp.14668 PMC 바로가기 [Article Type] article
Potential interactions between antineoplastic agents and medicines used to treat Covid-19Article Published on 2022-12-012022-11-15 Journal: Journal of Oncology Pharmacy Practice [Category] 치료제, [키워드] accounted Affect antineoplastic agents antineoplastic drug Baricitinib benefit Cancer Chloroquine Combination conducted COVID-19 disease drug drug combinations drug-drug interaction Drug-drug interactions Drug–drug interactions drug–drug interactions. Health Hydroxychloroquine identify Interaction interaction effect interactions involved Lexicomp Medicine Modification outcomes Patient Patients with cancer pharmacokinetic pharmacological intervention plasma concentration Potential professional risk severity therapeutic treat Treatment tyrosine kinase inhibitor was increased [DOI] 10.1177/10781552211040494 PMC 바로가기
Drug-Drug Interactions of Artemisinin-Based Combination Therapies in Malaria Treatment: A Narrative Review of the Literaturearticle Published on 2022-10-312024-09-01 Journal: Dent Cadmos [Category] 말라리아, [키워드] Artemisinin-based combination therapy Drug-drug interactions malaria Plasmodium falciparum [Article Type] article
Assessing the proportion of the Danish population at risk of clinically significant drug-drug interactions with new oral antivirals for early treatment of COVID-19Short communication Published on 2022-09-012022-10-05 Journal: International Journal of Infectious Diseases [Category] 임상, 치료법, 치료제, [키워드] Antiviral antiviral drug antivirals approved Assessing blockers claimed clinically COVID-19 Denmark drug drug-drug interaction Drug-drug interactions early treatment FIVE Guidance molnupiravir Nirmatrelvir/ritonavir objective patient safety Perspective predicted Prevent proportion Result risk severe COVID-19 severe COVID-19 disease severe disease statin Treatment were used [DOI] 10.1016/j.ijid.2022.06.059 [Article Type] Short communication
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021Article Published on 2022-09-012022-11-15 Journal: HIV medicine [Category] 치료제, [키워드] added adjusted AIDS antiretroviral antiretroviral treatment anxiety disorders anxiolytics backbone Bulevirtide Cancer cardiovascular disease Care children clinical Combination Comorbidities COVID-19 Delta diabete drug-drug interaction Drug-drug interactions drugs Dual therapy European European AIDS Clinical Society (EACS) Guidelines frailty Guidance guideline Health Hepatitis hepatitis B Hepatitis B virus hepatitis C virus HIV include inhibitor introduced Major management obesity opportunistic Infections opportunistic infections. Penta recommendation recommendations reduce risk Society therapy Transmission Treatment Tuberculosis Version virus women World Health Organization [DOI] 10.1111/hiv.13268 PMC 바로가기
How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies혈액암 환자와 세포 요법을 받는 환자의 COVID-19 치료 및 예방 방법Article Published on 2022-08-182022-09-11 Journal: Blood [Category] SARS, 변종, 임상, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration approach attenuate breakthrough infections Cell Cell therapy cell transplantation cellular therapy circulating circulating SARS-CoV-2 variants Clinical efficacy coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 in patient COVID-19 vaccine COVID-19 vaccines Drug-drug interactions Factors General population HCT Hematologic malignancy Hematopoietic cell transplantation higher risk Host Humoral response increased risk Infection morbidity morbidity and mortality Patient Postexposure Prophylaxis practicality Prevent progression recipient recipients SARS-CoV-2 Selection severe acute respiratory syndrome Coronavirus severe coronavirus disease severe COVID-19 Side effects therapeutic Therapies therapy treat Treatment virus [DOI] 10.1182/blood.2022016089 PMC 바로가기 [Article Type] Article